2nd CONGRESS 2020

20-21MARCH, 2020

TATA MEDICAL CENTERKOLKATA

2nd I-OSI CONGRESS 2020

Immuno-Oncology is a rapidly developing field of cancer and causing a paradigm shift in our approach to intractable issues in oncology hitherto. India and the surrounding regions carry a disproportionately large burdenof global cancer patients with a fraction of the resources. The emerging promise of immunotherapy will find wide applicability from developmentto end-use stages.

I-OSICON 2020 will focus on the latest developments and findingsin Immuno- Oncology including available treatments and those in development stage, and share Clinical experience in the use of Immunotherapy. The congress will welcome all disciplines of Oncology, Immunology, Researchers, Industry leaders, Regulators and Subject-experts.

With the introduction of this congress in the Indo-Pacific region we intendto provide an international platform for discussion of present and future challenges in Immunology education. National and international experts will present cutting-edge and practical clinical techniques based upon widely accepted evidence and will introduce new and emerging research.

Notably, the conference proceedings and abstracts will be published in an Indexed Journal.

We are inviting leading internationally acclaimed researchers, basic scientists and clinicians as faculty and expect a gathering large numberof attendees.

20-21 MARCH, 2020

2nd I-OSI CONGRESS 202020-21 MARCH, 2020

2nd I-OSI CONGRESS 202020-21 MARCH, 2020

2nd I-OSI CONGRESS 202020-21 MARCH, 2020

Patrons Prof. Mammen Chandy & Prof. S.V Chiplunkar

Conveners Prof. Hemant Malhotra & Prof. Moni Kuriakose

Chairperson(s) Prof. Deepak Mishra & Prof. Rakesh Jalali

Organizing Secretary Dr. Vivek Radhakrishnan

Scientific Committee Chair Prof. Reena Nair

Objectives:

1.To provide the Oncology and Scientific committee with a summary of the most significant advances in Immuno-Oncology.

2.To review evidence based management of Immuno-Therapy used in key Malignancies, from a Indian Perspective.

3.To discuss the continuum of care in patients undergoing Immuno-Therapy of Cancers.

Whom is it for:

I-OSI Congress is a two day Academic event, open to all practicing Medical Oncologists, Haematologists, Scientists, Biologists, Laboratory Physicians, Radiation Oncologists, Surgeons, Nursing personnel, Students, Fellows, Residents, General practitioners in oncology and other oncology healthcare professionals who have an interest in the fledgling field of Immuno-Oncology. We also welcome trade & Industries ongoing support for this important academic event.

2nd I-OSI CONGRESS 202020-21 MARCH, 2020

2nd I-OSI CONGRESS 202020-21 MARCH, 2020

What is this conference about:

The educational activity will include Scientific presentations, clinical case colloquium, evidence based management approaches, scientific abstracts and interactive discussions. Speakers and participants will include International & National Key Opinion leaders from the Clinical & Scientific Disciples associated with Immuno-Oncology. We also invite Clinicians to submit interesting case synopsis in relation to the practise of Immunotherapy of Cancer for the Clinical case colloquium.

The conference has been kept focused and short, to facilitate the presence and participation from one and all. Please do register, as your registration for the conference will enhance the scientific content of the conference by ensuring quality and minimising conflicts of interest.

In short we promise the proceedings to be a Scientific treat.

Regards,Vivek S Radhakrishnan Organizing Secretary, I-OSICon 2020

2nd I-OSI CONGRESS 202020-21 MARCH, 2020

2nd I-OSI CONGRESS 202020-21 MARCH, 2020

Registration for the conference is now open and is mandatory for all Faculty and Attendees.

a) Registrations should be done to the I-OSI Bank account( account details mentioned below). Kindly mail us at iosicon2020@gmail.com once you have made the registrations along with the transfer details. We will acknowledge the same in 2-3 days time.

b) Payment gateway link will be activated shortly.

ACCOUNT DETAILS

Name: IMMUNO ONCOLOGY SOCIETY OF INDIA

Account Number: 50100264162731

Bank: HDFC

Branch: Shapoorji Pallonji Building, Dr Shirodkar Marg, Near KEM Hospital, Opp Bata Showroom, Mumbai-400012, Maharashtra

IFS Code: HDFC0000357

For abstract submission please mail us at iosi20abstracts@gmail.comRules for the Abstract submission are mentioned in the Abstract page.